Logo Logo
Hilfe
Hilfe
Switch Language to English

Haenisch, Sierk; Rüden, Eva-Lotta von; Wahmkow, Hannes; Rettenbeck, Maruja L.; Michler, Christina; Russmann, Vera; Bruckmueller, Henrike; Waetzig, Vicki; Cascorbi, Ingolf und Potschka, Heidrun (2016): miRNA-187-3p-Mediated Regulation of the KCNK10/TREK-2 Potassium Channel in a Rat Epilepsy Model. In: ACS Chemical Neuroscience, Bd. 7, Nr. 11: S. 1585-1594

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Regulatory RNAs play a key role in the regulation of protein expression patterns in neurological diseases. Here we studied the regulation of miRNAs in a chronic rat model of temporal lobe epilepsy. The analysis was focused on a putative link with pharmacor-esponsiveness as well as the functional implications of the regulation of a selected miRNA. The findings did not reveal a difference in hippocampal miRNA expression between phenobarbital responders and nonresponders. However, when comparing rats following status epilepticus with control rats we identified 13 differentially expressed miRNAs with miRNA-187-3p being most strongly regulated. mRNAs encoding KCNK10/TREK-2 as well as DYRK2 were confirmed as targets of miRNA-187-3p. Expression of the potassium channel protein KCNK10/TREK-2 negatively correlated with hippocampal miRNA-187-3p expression and proved to be upregulated in the chronic phase of the epilepsy model. In conclusion, our data do not suggest a relevant impact of miRNA expression patterns on pharmacoresponsiveness. However, we confirmed regulation of miRNA-187-3p and demonstrated that it impacts the expression of the two-pore domain potassium channel protein KCNK10/TREK-2. Considering evidence from brain ischemia models, KCNK10/TREK-2 upregulation might serve a protective function with a beneficial impact on astrocytic potassium and glutamate homeostasis.

Dokument bearbeiten Dokument bearbeiten